Sonamed shipping Clarity System II EOAE/AABR hearing screening device in January.
This article was originally published in The Gray Sheet
SONAMED SHIPMENTS OF CLARITY SYSTEM II EOAE/AABR HEARING SCREENING device will begin in January 1996, the company says. The device, to be priced at about $25,000, is being billed as the first infant hearing screening and diagnostic tool to incorporate both evoked otoacoustic emissions testing and automated auditory brainstem response testing capabilities in a single device.
You may also be interested in...
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.
A lower first dose boosted the vaccine’s efficacy result, but AstraZeneca has conceded that this has to be proven in a separate trial. In the meantime, the UK government has asked the regulator to assess the vaccine under a special health emergency provision.